Zinger Key Points
- FiscalNote sells TimeBase to Thomson Reuters for $6.5 million to reduce debt.
- Company maintains 2025 revenue guidance despite divestiture’s financial impact..
- Don’t miss this list of 10 overlooked stocks—including one paying a 9% dividend—before Wall Street catches on.
FiscalNote Holdings Inc. NOTE agreed to sell its Australian subsidiary, TimeBase, to Thomson Reuters Corporation TRI for $6.5 million.
FiscalNote acquired TimeBase in 2021, bringing Australian legislative data services to its portfolio for legal professionals. Operating largely apart from FiscalNote's core customer base, TimeBase contributed just $1.3 million to the company's $120.3 million in 2024 GAAP revenue.
The divestiture is part of FiscalNote's effort to streamline operations, reduce debt, and refocus on its core strengths—particularly the enhanced PolicyNote platform, which will continue serving clients in the Australian market. Proceeds from the sale will be used to pay down the company's senior-term loan.
Also Read: Thomson Reuters Maintains Strong FY25 Outlook, Highlights Innovation, AI As Key Growth Drivers
Despite the financial impact of the divestiture, FiscalNote reaffirmed its full-year 2025 guidance, projecting revenue of $94 to $100 million (versus the consensus of $122.34 million) and adjusted EBITDA between $10 and $12 million. Management pointed to operational efficiencies and a more concentrated business model as drivers of sustained performance.
"This divestiture is another clear step in sharpening our strategic focus, improving our capital structure, and accelerating our path to positive free cash flow," said Josh Resnik, CEO and President of FiscalNote.
Thomson Reuters held Cash and cash equivalents of $1.37 billion as of March 31.
Price Action: NOTE shares are trading higher by 3.26% at 62 cents premarket at the last check Monday.
Now Read:
Edge Rankings
Price Trend
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.